Inotiv, Inc. (NASDAQ:NOTV) CEO Sells $281,216.94 in Stock

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 73,617 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.82, for a total value of $281,216.94. Following the completion of the sale, the chief executive officer now directly owns 956,592 shares in the company, valued at approximately $3,654,181.44. The trade was a 7.15 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Robert Jr. Leasure also recently made the following trade(s):

• On Friday, January 31st, Robert Jr. Leasure sold 22,700 shares of Inotiv stock. The stock was sold at an average price of $4.15, for a total transaction of $94,205.00.

Inotiv Price Performance

Inotiv stock opened at $4.06 on Friday. Inotiv, Inc. has a 1 year low of $1.23 and a 1 year high of $11.42. The company has a debt-to-equity ratio of 2.31, a quick ratio of 1.28 and a current ratio of 1.57. The firm has a 50 day moving average price of $4.33 and a 200 day moving average price of $2.96. The company has a market cap of $136.90 million, a price-to-earnings ratio of -0.88 and a beta of 3.58.

Inotiv (NASDAQ:NOTV) last released its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%. Sell-side analysts predict that Inotiv, Inc. will post -0.79 earnings per share for the current year.

Hedge Funds Weigh In On Inotiv

Large investors have recently modified their holdings of the company. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new stake in shares of Inotiv during the 4th quarter worth about $60,000. Virtu Financial LLC acquired a new position in Inotiv during the fourth quarter valued at approximately $76,000. Two Sigma Advisers LP grew its stake in Inotiv by 31.6% during the fourth quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock worth $93,000 after buying an additional 5,400 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Inotiv by 24.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 31,626 shares of the company’s stock worth $131,000 after acquiring an additional 6,216 shares in the last quarter. Finally, LPL Financial LLC purchased a new position in shares of Inotiv in the 4th quarter valued at $136,000. 18.17% of the stock is currently owned by hedge funds and other institutional investors.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.